Side effect of contraceptive implantation Etonogestrel,
Conditions
Interventions
Etonogestrel subdermal implantation,Etonogestrel subdermal implantation
Active Comparator Drug,Active Comparator Drug
Etonogestrel at immediate postpartum,Etonogestrel at delayed postpartum (6week)
Sponsors
Self funding
Self funding
Eligibility
Sex/Gender
Female
Age
10 Years to 20 Years
Inclusion criteria
Inclusion criteria: Postpartum women
Exclusion criteria
Exclusion criteria: Not willing to implantation as contraception Delivering baby before 6 week Can not record the information by herself Bleeding disorder Having anti-platelate, anti-coagulant or last dose fess than 3 months Diagnosed : Delayed postpartum haemorrhage Drug contraindication or allergy Denied to study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal bleeding duration 3 month Pictorial blood assessment chart | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaginal bleeding duration 6 month Pictorial blood assessment | — |
Countries
Thailand
Contacts
Public ContactWorawat Boonyachan
Phramongkutklao hospital
Outcome results
None listed